Form 8-K - Current report:
SEC Accession No. 0001564590-22-019849
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:27
Documents
13
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grph-8k_20220512.htm   iXBRL 8-K 37530
2 EX-99.1 grph-ex991_6.htm EX-99.1 265161
  Complete submission text file 0001564590-22-019849.txt   448685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grph-20220512.xsd EX-101.SCH 5585
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20220512_lab.xml EX-101.LAB 20057
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20220512_pre.xml EX-101.PRE 11933
7 EXTRACTED XBRL INSTANCE DOCUMENT grph-8k_20220512_htm.xml XML 3652
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 22917772
SIC: 2836 Biological Products, (No Diagnostic Substances)